Evidence map›Paper›PMID 32095252›Full record

ArticleJRSM open2020

An

Mohammed A Alzaid, Safa Eltahir, Muhammad Amin Ur Rahman, Wadha Alotaibi, Khalid Mobaireek

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JRSM open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mohammed A AlzaidPediatric Department, King Fahad Medical City, Saudi Arabia.ORCID https://orcid.org/0000-0001-5076-1965
Safa EltahirPathology Department, King Fahad Medical City, Saudi Arabia.
Muhammad Amin Ur RahmanPediatric Department, King Saud University, Saudi Arabia.
Wadha AlotaibiPathology Department, King Fahad Medical City, Saudi Arabia.
Khalid MobaireekPathology Department, King Fahad Medical City, Saudi Arabia.
King Fahd Medical City · SAKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurfactant protein C dysfunction is one of the causes of childhood interstitial lung disease but has not previously been reported in Arabian countries. CASE PRESENTATION: A six-year-old girl had presented at the age of eight months old with bronchiolitis followed by a persistent cough, dyspnea and hypoxaemia. She was found to have gastroesophageal reflux disease, but her symptoms did not resolve despite her therapy being optimised. Further tests, including a chest computed tomographic scan, lung biopsy and genetic testing, confirmed a diagnosis of surfactant protein C dysfunction.

conclusionWe report the first case in the Arab region of childhood interstitial lung disease caused by surfactant protein C deficiency.

Indexed as

childinterstitialprotein CSFTPCsurfactant

Identifiers

PMID32095252
PMCPMC7011330
OpenAlexW3004863236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.